This HTML5 document contains 85 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
n16http://dbpedia.org/resource/File:
foafhttp://xmlns.com/foaf/0.1/
n22https://global.dbpedia.org/id/
n21http://kannalife.com/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
n6http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:KannaLife
rdf:type
yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates dbo:Organisation owl:Thing yago:Group100031264 yago:DrugCompany108002578 yago:Company108058098 yago:WikicatCompaniesEstablishedIn2010 wikidata:Q24229398 n13:Agent n13:SocialPerson yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Agent schema:Organization wikidata:Q43229 wikidata:Q4830453 yago:WikicatCompaniesBasedInNewYork yago:WikicatCompaniesBasedInPennsylvania yago:Abstraction100002137 yago:Organization108008335 yago:SocialGroup107950920 yago:Institution108053576 dbo:Company
rdfs:label
KannaLife
rdfs:comment
Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE.
foaf:name
Kannalife Sciences Inc.
foaf:homepage
n21:
dbp:name
Kannalife Sciences Inc.
foaf:depiction
n6:Kannalife-logo.jpg
dbo:location
dbr:Doylestown,_Pennsylvania
dcterms:subject
dbc:Health_care_companies_established_in_2010 dbc:Health_care_companies_based_in_Pennsylvania dbc:American_companies_established_in_2010 dbc:Cannabis_research dbc:Pharmaceutical_companies_of_the_United_States dbc:2010_in_cannabis dbc:Companies_based_in_Bucks_County,_Pennsylvania
dbo:wikiPageID
40215057
dbo:wikiPageRevisionID
1113571932
dbo:wikiPageWikiLink
dbr:Neuropathix dbr:Chemotherapy-induced_peripheral_neuropathy dbr:Sports_Illustrated n16:Kannalife-logo.jpg dbr:Chronic_traumatic_encephalopathy dbc:American_companies_established_in_2010 dbc:Health_care_companies_based_in_Pennsylvania dbc:Cannabis_research dbr:Oxidative_stress dbr:Pharmaceutical_industry dbr:Doylestown,_Pennsylvania dbc:Pharmaceutical_companies_of_the_United_States dbr:NIH_Office_of_Technology_Transfer dbc:2010_in_cannabis dbr:Hepatic_encephalopathy dbc:Companies_based_in_Bucks_County,_Pennsylvania dbr:National_Institutes_of_Health dbr:Thoma_Kikis n16:US-patent-6630507.pdf dbr:Concussion dbc:Health_care_companies_established_in_2010
dbo:wikiPageExternalLink
n21:
owl:sameAs
yago-res:KannaLife wikidata:Q16998090 freebase:m.0wr61vd n22:fmdB
dbp:wikiPageUsesTemplate
dbt:Infobox_company dbt:Reflist dbt:Patent
dbo:thumbnail
n6:Kannalife-logo.jpg?width=300
dbp:assets
Exclusive License of patent
dbp:foundation
2010
dbp:founders
Dean Petkanas, Thoma Kikis
dbp:homepage
n21:
dbp:industry
dbr:Pharmaceutical_industry
dbp:location
dbr:Doylestown,_Pennsylvania
dbp:logo
250
dbp:type
Private
dbo:abstract
Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. In 2011, the company was granted an Exclusive License by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507, “Cannabinoids as Antioxidants and Neuroprotectants." Kannalife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA, for a target drug candidate, KLS-13019 to treat Chemotherapy-induced peripheral neuropathy, Hepatic encephalopathy, Mild Traumatic Brain Injury and CTE, an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE.
prov:wasDerivedFrom
wikipedia-en:KannaLife?oldid=1113571932&ns=0
dbo:wikiPageLength
5362
dbo:foundingYear
2010-01-01
dbo:foundedBy
dbr:Thoma_Kikis
dbo:industry
dbr:Pharmaceutical_industry
foaf:isPrimaryTopicOf
wikipedia-en:KannaLife